David M. Tanen

Corporate Officer

David M. Tanen

Corporate Officer

David Tanen is a member of the Board of Directors and Corporate Secretary of Neogene Therapeutics, Inc. In addition, he is a partner and co-founder of Two River Consulting, LLC, which specializes in creating, operating, and financing development-stage life science companies, where he has served as partner since its inception in 2004.

Prior to founding Two River, Mr. Tanen served as General Counsel of a life science focused venture capital firm. Mr. Tanen is also a Co-Founder of Kite Pharma, Inc., where he served as Corporate Secretary and General Counsel from its inception until its acquisition by Gilead Sciences in 2017. Mr. Tanen is a co-founder of Kronos Bio, Inc., a privately held biotechnology company, where he serves as a member of the Board of Directors and Corporate Secretary.  He is also a Co-Founder and Corporate Secretary of Allogene Therapeutics, Inc. (ALLO), and an advisor to Vida Ventures, LLC, a life science investment firm.

Mr. Tanen received his B.A. from The George Washington University and his J.D. from Fordham University School of Law, where he has served on the Dean’s Planning Council since 2009.